Lenvatinib for Progressive Differentiated Thyroid Cancer Treatment

Lenvatinib

Classification: Anticancer

Lenvatinib?

Lenvatinib is an anticancer medicine that is used for several advanced-stage cancers or metastatic cancers.

Uses of Lenvatinib

Advanced Kidney Cancer
Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Advanced Hepatocellular Carcinoma
Endometrial Carcinoma

How Does Lenvatinib Work?

It is a multiple tyrosine kinase inhibitor
It blocks several kinase enzymes
Inhibits angiogenesis
Causes cancer cells to starve and die

Common side effects include –

High BP
Tiredness
Diarrhea
Nausea
Loss of appetite
Weight decline
Hand and foot syndrome
Pain in muscles and joints
Delayed wound healing

Serious Side Effects

These are dose-dependent side effects that can be managed by supportive care.

Dizziness, seizures, and confusion
Stroke or heart failure
Elevated liver enzymes, acute liver failure
GIT perforations
Internal bleeding
Thrombosis

Precautions

To be cautiously used in patients with –

Heart disease
Renal disorder
Liver disorder
Elderly patients

Contraindication

Allergy or hypersensitivity to Lenvatinib and its components
Breastfeeding mothers
Pregnant women

Warning

To be used under medical prescription only

Important Safety and Monitoring Information

Regular monitoring of liver function
Cardiac functions
Blood pressure
Neurological condition
Renal function

Gandhi Medicos: Years of Trusted Excellence in Oncology Care

At Gandhi Medicos, we’ve spent years at the heart of global cancer treatment—delivering hope, healing, and high-quality anticancer medicines to every corner of the world. As a leading global exporter and supplier, we provide a wide spectrum of branded and generic oncology therapies trusted by oncologists and patients alike.